ProPhase Labs, Inc. (PRPH) stock
PRPHOTCPharmaceutical PreparationsFiscal year ends December 31
$0.01−0.00 (-6.16%)
Close on Oct 19, 2026Market cap $119.68KP/E –Yield –
ProPhase Labs total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
ProPhase Labs's total debt was $2.45M at Mar 31, 2025. For fiscal 2024 it was $3.21M, up 9.7% from the year before. The highest annual figure on record is $3.21M in fiscal 2024.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $3.21M | +9.7% |
| FY2023 | Dec 31, 2023 | $2.92M | – |
| FY2022 | Dec 31, 2022 | $0 | -100.0% |
| FY2021 | Dec 31, 2021 | $44.00K | -97.0% |
| FY2015 | Dec 31, 2015 | $1.47M | +1366.0% |
| FY2014 | Dec 31, 2014 | $100.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2025 | Mar 31, 2025 | $2.45M | +2.9% |
| Q4 FY2024 | Dec 31, 2024 | $3.21M | +9.7% |
| Q3 FY2024 | Sep 30, 2024 | $2.67M | -63.0% |
| Q2 FY2024 | Jun 30, 2024 | $3.26M | – |
| Q1 FY2024 | Mar 31, 2024 | $2.38M | +13127.8% |
| Q4 FY2023 | Dec 31, 2023 | $2.92M | +6545.5% |
| Q1 FY2023 | Mar 31, 2023 | $7.22M | +8818.5% |
| Q4 FY2022 | Dec 31, 2022 | $0 | – |
| Q1 FY2022 | Mar 31, 2022 | $18.00K | – |
| Q4 FY2021 | Dec 31, 2021 | $44.00K | – |
| Q3 FY2021 | Sep 30, 2021 | $81.00K | – |
See a number that looks wrong?